Skip to main content

Table 1 Demographics, on-arrival presentation, and treatment response by group

From: Oral clonazepam versus lorazepam in the treatment of methamphetamine-poisoned children: a pilot clinical trial

Variable Total
(n = 30)
Lorazepam
(n = 15)
Clonazepam
(n = 15)
P
(MWU test)
  Median [IQR] (range)  
Age (months) 15 [10, 36]
(6, 144)
15 [10, 37]
(6, 144)
17 [11, 33]
(6, 84)
0.637
Weight (kg) 11 [10,14]
(6.5, 40)
11.5 [9.5, 15]
(8, 40)
10.7 [10,, 13.7]
(6.5, 25)
0.697
Time elapsed between exposure and presentation (h) 3 [5,6]
(1, 72)
5 [4,9]
(2, 72)
3 [5,6]
(1, 14)
0.377
Time elapsed between exposure and the development of symptoms (h) 1 [1,2]
(0.5, 24)
1 [1,, 2.2]
(0.5, 24)
1 [1,2]
(0.5, 2)
0.275
Presentation on arrival     
Temperature (C) 37 [36.5, 37]
(36, 37.7)
36.9 [36.5, 37]
(36, 37.3)
37 [36.7, 37.1]
(36.5, 37.5)
0.142
Systolic BP (mmHg) 90 [90, 100]
(80, 110)
92 [90, 100]
(80, 110)
90 [90, 100]
(80, 110)
0.400
Diastolic BP (mmHg) 50 [50, 60]
(40, 80)
60 [50, 70]
(50, 80)
50 [50, 60]
(40, 70)
0.160
Heart rate (per minute) 127 [110, 140]
(90, 160)
130 [110, 150]
(92, 160)
120 [102, 140]
(90, 150)
0.498
Respiratory rate (per minute) 30 [27, 35]
(16, 60)
31[26, 35]
(22, 60)
30 [28, 34]
(16, 60)
0.667
Creatine phosphokinase (U/L) 218 [148, 360]
(88, 1584)
225 [148, 461]
(117, 698)
211[126, 324]
(88, 1584)
0.697
Treatment response     
Duration of symptoms (h) 4 [3,5]
(2, 20)
3 [2,4]
(2, 13)
5 [3,7]
(2, 20)
0.166
Hospitalization period (h) 24 [24, 48]
(24, 72)
24 [24, 48]
(24, 48)
24 [24, 42]
(24, 72)
0.525